Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1843 1
1962 2
1963 1
1965 1
1966 1
1967 4
1968 4
1969 3
1970 1
1972 1
1973 2
1974 3
1975 1
1978 1
1979 2
1980 2
1981 1
1984 3
1987 2
1988 1
1991 2
1992 3
1993 1
1994 1
1995 1
1996 2
1998 1
1999 2
2002 1
2003 1
2004 1
2005 1
2006 1
2008 1
2009 1
2010 1
2011 1
2012 2
2013 2
2014 6
2015 4
2016 4
2021 2
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
Coincident PAMM and AMN and Insights Into a Common Pathophysiology.
Iovino C, Au A, Ramtohul P, Bacci T, AlBahlal A, Khan AM, Al-Abdullah AA, Wendel R, Chhablani J, Sadda S, Freund KB, Sarraf D. Iovino C, et al. Among authors: wendel r. Am J Ophthalmol. 2022 Apr;236:136-146. doi: 10.1016/j.ajo.2021.07.004. Epub 2021 Jul 18. Am J Ophthalmol. 2022. PMID: 34283978
Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials.
Xue K, Hua P, Maguire MG, Daniel E, Jaffe GJ, Grunwald JE, Ying GS; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Xue K, et al. Ophthalmol Retina. 2023 Jul;7(7):564-572. doi: 10.1016/j.oret.2023.02.008. Epub 2023 Feb 19. Ophthalmol Retina. 2023. PMID: 36803692 Clinical Trial.
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Core JQ, Pistilli M, Hua P, Daniel E, Grunwald JE, Toth CA, Jaffe GJ, Martin DF, Maguire MG, Ying GS; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Core JQ, et al. Ophthalmol Retina. 2022 Sep;6(9):771-785. doi: 10.1016/j.oret.2022.03.024. Epub 2022 Apr 9. Ophthalmol Retina. 2022. PMID: 35405352 Free PMC article. Clinical Trial.
Multimodal imaging in persistent placoid maculopathy.
Gendy MG, Fawzi AA, Wendel RT, Pieramici DJ, Miller JA, Jampol LM. Gendy MG, et al. Among authors: wendel rt. JAMA Ophthalmol. 2014 Jan;132(1):38-49. doi: 10.1001/jamaophthalmol.2013.6310. JAMA Ophthalmol. 2014. PMID: 24310266
Expanded indications for pneumatic retinopexy.
Tornambe PE, Hilton GF, Kelly NF, Salzano TC, Wells JW, Wendel RT. Tornambe PE, et al. Among authors: wendel rt. Ophthalmology. 1988 May;95(5):597-600. doi: 10.1016/s0161-6420(88)33135-0. Ophthalmology. 1988. PMID: 3174020
81 results